FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...

Neuraly and Enigma Biomedical have signed an agreement for PMI04, a positron emission tomography (PET) imaging biomarker for ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM ...

Presence of a protein-binding biomarker in a small cohort of adults with depression may be an indicator that suicidal ...

Most nuclear medicine technologists are employed in hospital settings, where they contribute to the diagnosis and treatment.

These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...

Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission ...

ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel ...

The agreement is to sell 100% of LHC’s interest in LMI for an upfront payment of $350 million (about R6. 48 billion) and ...